Concordmed Business Summary

Concord Medical Co., Ltd. (6518.TWO) is a Taiwan-based healthcare services firm that generates revenue through a vertically integrated model encompassing hospital management consulting, medical equipment leasing, and the integrated supply of pharmaceuticals and medical consumables. The company specializes in supporting community hospitals by providing comprehensive nursing staffing, medical training, and procurement solutions for clinical instruments and reagents. Additionally, it operates a consumer health division under its own brand, developing medical aesthetic skincare, health foods, and topical Chinese medicine. Concord Medical competes directly with local peers such as Hi-Clearance (1788), CHC Healthcare Group (4164), Medical Imaging Corporation (6637), and ShareHope Medicine (8403), maintaining a specialized market position as a primary operational partner for smaller, community-based medical institutions in Taiwan. The company is led by Chairman and CEO Liu Jing-Yi, a veteran administrator with nearly 40 years of experience in clinical management and a Master’s in Hospital Administration from National Yang Ming Chiao Tung University. The executive team includes General Manager Lin Jia-Hong, who brings a background in strategic planning from BenQ and AUO, and CFO Liu Fu-An, formerly of Sinphar Pharmaceutical. Vice Chairman Yang Hong-Pei provides significant industrial pedigree, concurrently serving as Vice President of Qisda Corporation and head of its medical device division. Founded in 2009, the company is a key member of the BenQ Group (明基友達集團) ecosystem, which serves as a major strategic investor and provides a robust technological and financial foundation for its expansion into Southeast Asian and Chinese markets.